Skip to content
  • Career
  • Support
  • Contact Us
Menu
  • Career
  • Support
  • Contact Us
  • Solutions
    • Clinical Services
    • Research Services
  • Get Started
    • Get Set Up
    • Get a Quote
  • Science
    • What We Do
    • How We Do It
    • Why It Matters
    • Our Core Areas
    • Technology
  • News & Events
    • News
    • Events
  • Resources
    • Webinars
    • Publications
    • Whitepapers
    • Report References
    • Media
  • About Us
    • About AMRA
    • The Team
    • Partners & Investors
Menu
  • Solutions
    • Clinical Services
    • Research Services
  • Get Started
    • Get Set Up
    • Get a Quote
  • Science
    • What We Do
    • How We Do It
    • Why It Matters
    • Our Core Areas
    • Technology
  • News & Events
    • News
    • Events
  • Resources
    • Webinars
    • Publications
    • Whitepapers
    • Report References
    • Media
  • About Us
    • About AMRA
    • The Team
    • Partners & Investors
Search
Close
Menu
  • Solutions
    • Clinical Services
    • Research Services
  • Get Started
    • Get a Quote
    • Get Set Up
  • News & Events
    • News
    • Events
  • Science
    • What We Do
    • How We Do It
    • Why It Matters
    • Our Core Areas
    • Technology
  • Resources
    • Webinars
    • Publications
    • Whitepapers
    • Report References
    • Media
  • About Us
    • About AMRA
    • The Team
    • Partners & Investors
  • Career
  • Support
  • Contact Us
  • All posts

AMRA Medical Will Present a Study on MRI-Based Body Composition in Liver Disease at The Digital International Liver Congress 2020

  • August 20, 2020

AMRA Medical and Linköping University collaborated on a liver biopsy-controlled MRI-based body composition study and will present the results at the congress.

Linköping, Sweden, August 20, 2020: AMRA, in partnership with Linköping University, investigated body composition in liver needle biopsy-controlled patients with various chronic liver diseases using magnetic resonance imaging (MRI) and will share the results at EASL’s The Digital International Liver CongressTM 2020, 27-29 August.

AMRA analyzed abdominal MR images of 90 patients with suspected chronic liver disease. Liver needle biopsies were performed within an hour of MRI for definite diagnosis and fibrosis staging – 34 had Non-Alcoholic Fatty Liver Disease (NAFLD) and 56 had other etiologies. AMRA specifically quantified visceral adipose tissue (VAT) and muscle fat infiltration (MFI) of the spinal erectors using AMRA® Researcher – which automates the volumetric assessment of MR images.

The researchers found that the NAFLD group had significantly higher VAT (normalized by height) and MFI compared to other etiologies, and, surprisingly, in patients with NAFLD, MFI increased with stage of fibrosis, which suggests sarcopenic activity, elevated metabolic dysfunction, or both.

Previous studies have shown that sarcopenia, or adverse muscle composition, develops almost universally in patients with cirrhosis, leads to more pre-, peri-, and post-operative complications, and is associated with NAFLD comorbidities. It lowers post-operative survival in liver transplant settings, and negatively impacts treatment outcome. In another study from AMRA, assessing muscle volume, in combination with muscle fat, was shown to be more strongly associated to muscle and mobility function compared to muscle volume alone1.

The ability to differentiate muscle composition between patients with chronic liver disease such as NAFLD can potentially equip researchers with objective clinical endpoints. AMRA’s method reduces image analysis time via automated image calibration, labelling, and registration of fat and muscle regions, which is usually performed manually.

Annually, roughly 10,000 scientific and medical experts from a broad range of fields come together at the ILC to learn about the latest liver research. This year, owing to COVID-19, the event is entirely online, as The Digital International Liver Congress™. AMRA will present “Muscle fat is higher in NAFLD, and increases with fibrosis stage – a retrospective liver biopsy controlled magnetic resonance imaging-based body composition study”.

Learn more about AMRA’s research, capabilities, and opportunities for collaboration by attending AMRA’s digital poster presentation at (https://ilc-congress.eu/about-ilc-2020/) and visiting www.amramedical.com.

 

About AMRA Medical

AMRA is a ground-breaking international digital health company at the forefront of medical imaging and precision medicine. The company has developed a new global standard in body composition assessment, the ability to automatically produce multiple fat and muscle biomarkers with unrivaled precision and accuracy, as well as contextual disease insights – all from a single, rapid, whole-body MRI. AMRA’s  aim is  to support transformative care and vital decision-making from clinical research to health and wellness.

 

Contact

Rosemary Shull
SVP Global BD & Marketing
rosemary.shull@amramedical.com

 

1  Linge J, et al (2019) On the Definition of Sarcopenia in the Presence of Aging and Obesity—Initial Results from UK Biobank, The Journals of Gerontology: Series A, https://doi.org/10.1093/gerona/glz229

 

  • All posts
Follow us
Linkedin Twitter Facebook

About

AMRA offers clinical services and research services to support transformative care and vital decision-making, from clinical research to clinical care.

Contact

  • info@amramedical.com
  • +46 (0) 13 16 26 00
  • Contact Our Support
  • Data Privacy Policy
  • Cookie Policy
  • Data Privacy Policy
  • Cookie Policy

Newsletter

    © 2023 AMRA Medical AB

    AMRA Medical
    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage vendors Read more about these purposes
    View preferences
    {title} {title} {title}
    AMRA Medical
    Manage Cookie Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    Manage options Manage services Manage vendors Read more about these purposes
    View preferences
    {title} {title} {title}